8 months ago
Australia Warns on Fake Rabies Vaccine
Australia's health advisory group told travelers that a rabies vaccine called Abhayrab, made in India, might not be safe if they got it after November 1, 2023.
The vaccine company, Indian Immunologicals Limited (IIL), said this warning is too strict and only one batch of the vaccine was affected.
They found a problem with that batch in January 2025 and told the Indian government.
The company said the vaccine is usually safe and asked Australia to change its warning.
They also said the bad batch is no longer being sold.
The vaccine has been used in India and other countries for a long time and is generally safe.
Australia's ATAGI advised travelers to consider Abhayrab rabies vaccine invalid if received after November 1, 2023.
IIL refuted the advisory, stating only one specific batch (KA24014, March 2024) was counterfeited and identified in January 2025.
IIL proactively notified Indian regulators and law enforcement about the counterfeit batch and ensured swift action.
The counterfeit batch is no longer available, and IIL emphasized the overall safety and efficacy of their vaccine.
IIL requested ATAGI to review the advisory to prevent public anxiety and mistrust in vaccines.
- Who
- Australian Technical Advisory Group on Immunisation (ATAGI) and Indian Immunologicals Limited (IIL)
- What
- Advisory against a specific batch of rabies vaccine, Abhayrab, due to counterfeiting concerns
- Where
- Australia and India
- When
- Advisory issued around a week ago, counterfeit batch identified in January 2025
- Why
- Concerns over the validity and safety of a specific batch of the vaccine
Australia's Advisory
India's Clarification
Timing of Counterfeit Vaccines
Australia's Advisory
Counterfeit batches have been circulating since 2023.
India's Clarification
Only one specific batch (KA24014) was counterfeited and identified in January 2025.
Vaccine Validity
Australia's Advisory
People vaccinated with Abhayrab after November 1, 2023, may not be fully protected.
India's Clarification
The counterfeit batch is no longer available, and the vaccine is generally safe and effective.
Advisory Impact
Australia's Advisory
Travellers and healthcare providers should replace doses with valid vaccines registered in Australia.
India's Clarification
The advisory is over-cautious and misplaced, causing unnecessary public anxiety.
Key facts
- Vaccine Name
- Abhayrab
- Manufacturer
- Indian Immunologicals Limited (IIL)
- Batch Number
- KA24014
- Manufacturing Date
- March 2024
- Expiry Date
- February 2027
- Identified Counterfeit
- January 2025
- Market Share in India
- 40%
- Total Doses Supplied
- 210 million
Timeline
Indian Immunologicals Limited ignored safety alarms on Abhayrab vaccine, experts warned.
Failure to act sparks Australian health alert against post-November batches.
Manufacturer disputes severity as Aussies urge caution.
Quotes
Dr MK Sudarshan
Founder president of the Association for Prevention and Control of Rabies in India
“Fortunately, people in India are usually administered five doses of the vaccine following an animal bite. Now, even if one of the vaccines is of doubtful efficacy — and we still do not know what the counterfeit vaccines contained — the person will still be protected if they have received the other doses and the immunoglobulin.”
indianexpress.com
“In rare cases, rabies might happen despite vaccination if the wound has not been cleaned properly and on time. If the bite happens in a nerve-rich area and sends the virus directly into the nervous system, the infection may occur.”
indianexpress.com
UK Health Advisory
Public health agencies in the United Kingdom
“The public health agencies in the four nations of the UK are conducting a look-back exercise to identify any travellers who reported receiving rabies vaccine following an animal bite in India from November 2023 onwards, to determine whether further rabies vaccination may be recommended.”
indianexpress.com
United States Centre for Disease Control and Prevention
US health agency
“A case of rabies has been reported in the US in a traveler from India. The circulation of counterfeit Abhayrab human rabies vaccine has recently been reported in major cities in India. Counterfeit vaccines may not be effective in the prevention of rabies and could contain harmful ingredients.”
indianexpress.com
Indian Immunologicals
Manufacturer of the Abhayrab vaccine
“In January 2025, IIL proactively identified in the market one specific batch (#KA24014) with a packaging different to the original. The company immediately notified the Indian regulators and law enforcement agencies…. There is no instance of any other counterfeit batch in the market.”
indianexpress.com
An expert in the know of the matter
Expert knowledgeable about the counterfeit vaccine issue
“The counterfeit products were seized and tested, including in the government’s Central Drug Testing Laboratory in Kasauli, which tests all vaccines before they are released in the Indian market. The test report, in fact, found the vaccines to contain the genuine product. What this essentially means is that the outer package of the product was changed to divert the government supply to the open market.”
indianexpress.com
A senior official from the company
Senior official from Indian Immunologicals
“We are the largest producer of rabies vaccine in the world and have been delivering the product for the last 25 years. The challenge with such advisories is that it may lead to more vaccine hesitancy within the country. Imagine if Abhayrab is the only rabies vaccine on the shelf in a village — and someone does not take it because of this news. We want to let people know that the vaccine is safe and effective.”
indianexpress.com
Sources
Australia warns against counterfeit rabies vaccine in India: What advisory says and how 'Abhayrab' manufacturer reacted
Indian vaccine maker seeks review of Australian alert on counterfeit rabies shots - Telegraph India
After Australia's advisory against Abhayrab rabies vaccine, maker says issue limited to one batch
Fake Rabies Vaccine Advisory Explained: What Australia Warned, What India Clarified
Indian Immunologicals writes to Australian health authorities about counterfeit rabies vaccine
Fake rabies vaccine: IIL says real Abhayrab safe after Australia alert, calls it isolated case
Fake rabies vaccine available in India since 2023, claims Australia: Pharma co refutes charges
Over-cautionary: Manufacturer on Australia’s advisory against its rabies vaccine
Australia Flags Indian Rabies Vaccine
Countries raise concern about ‘fake rabies vaccine’ in India: The case, the implications
Indian Vaccine Maker Hits Back At Australia’s ‘Fake Rabies Shot’ Alarm — Demands Urgent Review




